Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics-Reference-Cited by-同舟云学术

Leukemia stem cell immunophenotyping tool for diagnostic, prognosis, and therapeutics

Published:2019-11-10 Issue:6 Volume:235 Page:4989-4998
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Mastelaro de Rezende Marina¹^ORCID,Ferreira Alice T.²,Paredes‐Gamero Edgar J.¹³

Affiliation:

1. Departamento de BioquímicaUniversidade Federal de São Paulo (UNIFESP) São Paulo Brazil

2. Departamento de BiofísicaUniversidade Federal de São Paulo (UNIFESP) São Paulo Brazil

3. Division ‐ Faculdade de Ciências Farmacêuticas, Alimentos e NutriçãoUniversidade Federal do Mato Grosso do SulCampo Grande Mato Grosso do Sul Brazil

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.29394

Reference50 articles.

1. Sex differences in the GSK3β-mediated survival of adherent leukemic progenitors

2. The molecular signature of AML with increased ALDH activity suggests a stem cell origin

3. A Proteomics and Transcriptomics Approach to Identify Leukemic Stem Cell (LSC) Markers

4. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA Damage-Inducing 10-Methoxy-canthin-6-one (Mtx-C) Promotes Cell Cycle Arrest in G₂/M and Myeloid Differentiation of Acute Myeloid Leukemias and Leukemic Stem Cells;ACS Omega;2024-08-22

2. Advances in single-cell RNA sequencing and its applications in cancer research;Journal of Hematology & Oncology;2023-08-24

3. Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets;Expert Opinion on Investigational Drugs;2023-02-01

4. DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax;Theranostics;2023

5. The Translational Landscape Revealed the Sequential Treatment Containing ATRA plus PI3K/AKT Inhibitors as an Efficient Strategy for AML Therapy;Pharmaceutics;2022-10-28